[Right ventricle free wall rupture during transcatheter occluder implantation in a patient with postinfarction rupture of the interventricular septum and COVID-19-associated myocarditis. Case report].

Autor: Pevzner DV; Chazov National Medical Research Center of Cardiology., Sukhinina TS; Chazov National Medical Research Center of Cardiology., Anufriev EN; Chazov National Medical Research Center of Cardiology., Kostritca NS; Chazov National Medical Research Center of Cardiology., Avetisyan EA; Chazov National Medical Research Center of Cardiology., Shitov VN; Chazov National Medical Research Center of Cardiology., Kurilina EV; Chazov National Medical Research Center of Cardiology., Osiev AG; MEDSI Group of Companies., Merkulov EV; Chazov National Medical Research Center of Cardiology., Tereshchenko AS; Chazov National Medical Research Center of Cardiology., Boytsov SA; Chazov National Medical Research Center of Cardiology.
Jazyk: ruština
Zdroj: Terapevticheskii arkhiv [Ter Arkh] 2023 Sep 29; Vol. 95 (7), pp. 574-579. Date of Electronic Publication: 2023 Sep 29.
DOI: 10.26442/00403660.2023.07.202330
Abstrakt: Intraventricular septum rupture is a rare mechanic complication of myocardial infarction associated with high mortality. This case describes STEMI in recovered patient after COVID 19 associated pneumonia, which was complicated by ventricular septum rupture followed by cardiogenic shock. It was managed by percutaneous occluder implantation. The procedure was complicated by right ventricular wall rupture. Postmortem examination of myocardium showed the signs of inflammation infiltrate and myocyte necrosis, according to histopathological Dallas criteria diagnosis of COVID-19 associated myocarditis was established. The COVID-19 pandemic has contributed to increasing cardiovascular mortality. This is typically attributed to diminishing resources for timely and appropriate medical care, and patients' late presentations for fear of contracting the infection. Cardiovascular complication of COVID-19 may be another contributing factor. Further research is needed to improve our understanding of the mechanisms and long-term sequelae of myocardium damage in COVID-19, to optimize treatment strategy and subsequent follow-up in such patients.
Databáze: MEDLINE